Diamond Hill Capital Management LLC Investment Advisor Purchases New Position in Aurinia Pharmaceuticals Inc $AUPHMarket Beat·18 hours agoAUPH+0.07%DHIL0.00%
Aurinia Pharmaceuticals (NASDAQ:AUPH) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPSMarket Beat·Aug 6 at 05:26 PMAUPH+0.07%
Aurinia publishes corporate presentation outlining LUPKYNIS growth strategy, aritinercept development plansPUBT·Aug 6 at 07:28 AMAUPH+0.07%
Aurinia Q2 net income climbs 74% to $37.4 million; revenue rises 19% to $83.2 millionPUBT·Aug 6 at 07:08 AMAUPH+0.07%
Aurinia Pharma | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 83.22 MEarnings Watch·Aug 6 at 07:05 AMAUPH+0.07%
Earnings Beats and Executive Shake-Ups Reshape U.S. Mid-Cap Equities in 2026Global Report·Aug 6 at 04:14 AMHELP+0.86%GRBK-2.16%
Renaissance Technologies LLC Acquires 73,700 Shares of Aurinia Pharmaceuticals Inc $AUPHMarket Beat·Jul 30 at 04:05 AMAUPH+0.07%
Micro-Cap Liquidity Crunch Contrasts with Semi-Equip Boom in 2026 Mixed Equities CheckGlobal Report·Jul 28 at 04:13 AMCOHU-5.43%AUPH+0.07%
Aurinia Pharmaceuticals (AUPH) Launches PRESERVE Study, Is A 5% Undervalued View Enough?Simplywall·Jul 8 at 02:59 AMAUPH+0.07%
TD Cowen Reaffirms Their Buy Rating on Aurinia Pharmaceuticals (AUPH)Tip Ranks·Jul 6 at 02:35 PMAUPH+0.07%
Aurinia Pharmaceuticals posts corporate presentation on LUPKYNIS growth, autoimmune disease pipeline focusPUBT·Jul 6 at 07:15 AMAUPH+0.07%
